Can fasting plus weights strengthen aging bones?

NCT ID NCT07824375

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 17, 2026 · Last updated Sep 18, 2026 · Updated 1 time

Summary

Researchers at the University of Alabama at Birmingham are testing whether combining time-restricted eating with supervised resistance exercise can improve bone health in adults with osteopenia. Participants are 50 to 75 years old with low bone density and higher body weight. One group eats within an 8-hour window and lifts weights three days a week for 12 weeks, while the other keeps their usual eating pattern and does the same exercise. The study measures changes in bone mineral density and bone mineral content.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
time-restricted eating combined with supervised resistance exercise
What this could lead to
If it works, this could offer a low-cost lifestyle approach to slowing bone loss in adults with osteopenia.
What could go wrong
The trial is small and short, so any bone changes may be too slight to detect or may not last. Time-restricted eating can also make it harder to eat enough protein and calories for bone and muscle.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 24 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Nov 2026

An estimate. Start dates often move.

Expected to finish

Apr 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

50 to 75 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Men and women aged 50-75 years with body mass index (BMI) \>25kg/m2 * Osteopenia, defined as a T score between -1.0 and -2.5 at the lumbar spine, femoral neck, or total hip * Elevated adiposity, defined by waist circumference \>102 cm in men or \>88 cm in women * Stable health history over the past 2 months * Stable medication history over the past 2 months, as recommended by the primary provider * Willing and able to provide informed consent Exclusion Criteria: * Participation in a formal weight loss program, intentional caloric restriction, fasting \>10 hours/day, or ≥10 pounds weight loss within the past 3 months * Current participation in structured exercise training, supervised rehabilitation, or \>150 minutes/week of moderate intensity physical activity * Medical conditions or use of medications affecting bone metabolism * Diagnosed diabetes or use of insulin or glucose lowering medications * Resting heart rate \>120 beats/minute or daytime blood pressure ≥180/100 mmHg * Unstable angina, myocardial infarction, or stroke within the past 3 months * Continuous supplemental oxygen use for chronic pulmonary disease or heart failure * Rheumatoid arthritis, Parkinson's disease, dialysis, active cancer treatment within the past year, or diagnosed cognitive impairment * Absolute contraindications to exercise training according to American College of Sports Medicine guidelines * Unable to fast for 16 hours * Any condition that in the opinion of the investigator would impair ability to participate in the trial

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Osteopenia are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Bone Diseases, Metabolic

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • University of Alabama at Birmingham

    Birmingham, Alabama, 35294, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.